Pan-cancer profiling of the effect of biopsied site on tumor mutational burden measurements in a real-world data cohort

被引：0
|
作者：
Papillon-Cavanagh, Simon [1 ]
Gao, Chuan [1 ]
Han, G. Celine [1 ]
Walsh, Alice M. [1 ]
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2008
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Burden of Disease of Breast Cancer in Italy: A Real-World Data Analysis
    Mennini, F. S.
    Marcellusi, A.
    Sciattella, P.
    Scortichini, M.
    Ragonese, Angela
    Cattel, F.
    D'Antona, R.
    Del Mastro, L.
    Gori, S.
    Perrone, G.
    Migliorini, R.
    Trabucco Aurilio, M.
    PHARMACOECONOMICS-OPEN, 2025, 9 (02) : 283 - 290
  • [42] An artificial intelligence framework integrating longitudinal electronic health records with real-world data enables continuous pan-cancer prognostication
    Morin, Olivier
    Vallieres, Martin
    Braunstein, Steve
    Ginart, Jorge Barrios
    Upadhaya, Taman
    Woodruff, Henry C.
    Zwanenburg, Alex
    Chatterjee, Avishek
    Villanueva-Meyer, Javier E.
    Valdes, Gilmer
    Chen, William
    Hong, Julian C.
    Yom, Sue S.
    Solberg, Timothy D.
    Lock, Steffen
    Seuntjens, Jan
    Park, Catherine
    Lambin, Philippe
    NATURE CANCER, 2021, 2 (07) : 709 - +
  • [43] Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness
    Quintanilha, Julia C. F.
    Storandt, Michael H.
    Graf, Ryon P.
    Li, Gerald
    Keller, Rachel
    Lin, Douglas I.
    Ross, Jeffrey S.
    Huang, Richard S. P.
    Schrock, Alexa B.
    Oxnard, Geoffrey R.
    Chakrabarti, Sakti
    Mahipal, Amit
    JCO PRECISION ONCOLOGY, 2023, 7
  • [44] Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors
    Lee, Jessica K.
    Sivakumar, Smruthy
    Schrock, Alexa B.
    Madison, Russell
    Fabrizio, David
    Gjoerup, Ole
    Ross, Jeffrey S.
    Frampton, Garrett M.
    Napalkov, Pavel
    Montesion, Meagan
    Schutzman, Jennifer L.
    Ye, Xin
    Hegde, Priti S.
    Nagasaka, Misako
    Oxnard, Geoffrey R.
    Sokol, Ethan S.
    Ou, Sai-Hong Ignatius
    Shi, Zhen
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [45] Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors
    Jessica K. Lee
    Smruthy Sivakumar
    Alexa B. Schrock
    Russell Madison
    David Fabrizio
    Ole Gjoerup
    Jeffrey S. Ross
    Garrett M. Frampton
    Pavel Napalkov
    Meagan Montesion
    Jennifer L. Schutzman
    Xin Ye
    Priti S. Hegde
    Misako Nagasaka
    Geoffrey R. Oxnard
    Ethan S. Sokol
    Sai-Hong Ignatius Ou
    Zhen Shi
    npj Precision Oncology, 6
  • [46] Pan-cancer analysis of clinical acquired resistance (AR) in BRAF-driven real-world cases
    Pietrantonio, F.
    Lee, J.
    Boussemart, L.
    Schinke, C.
    Srkalovic, G.
    Madison, R.
    Ross, J. S.
    Miller, V. A.
    Alexander, B. M.
    Ali, S. M.
    Schrock, A. B.
    Daniels, G. A.
    ANNALS OF ONCOLOGY, 2019, 30 : 762 - +
  • [47] Development of a prediction model for suicidal ideation in patients with advanced cancer: A multicenter, real-world, pan-cancer study in China
    He, Yi
    Pang, Ying
    Yang, Wenlei
    Su, Zhongge
    Wang, Yu
    Lu, Yongkui
    Jiang, Yu
    Zhou, Yuhe
    Han, Xinkun
    Song, Lihua
    Wang, Liping
    Li, Zimeng
    Lv, Xiaojun
    Wang, Yan
    Yao, Juntao
    Liu, Xiaohong
    Zhou, Xiaoyi
    He, Shuangzhi
    Zhang, Yening
    Song, Lili
    Li, Jinjiang
    Wang, Bingmei
    Ke, Yang
    He, Zhonghu
    Tang, Lili
    CANCER MEDICINE, 2024, 13 (12):
  • [48] Ancestry-associated differences in somatic mutation rates from tumor profiling data of a pan-cancer cohort of 100,000 patients
    Rhead, Brooke
    Pouliot, Yannick
    Guinney, Justin
    de la Vega, Francisco M.
    CANCER RESEARCH, 2023, 83 (07)
  • [49] Use of a tissue-free epigenomic circulating tumor DNA (ctDNA) assay for quantification of tumor fraction (TF) and association with outcomes from RADIOHEAD real-world advanced pan-cancer cohort.
    Wienke, Sara
    Gordon, Sean
    Liang, Samantha
    Wang, Jing
    Barnett, Reagan
    Chang, Kyle
    Zhang, Shile
    Espenschied, Carin R.
    Quinn, Katie
    Connolly, John
    Banks, Kimberly
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Increased KRAS G12C Prevalence, High Tumor Mutational Burden, and Specific Mutational Signatures Are Associated With MUTYH Mutations: A Pan-Cancer Analysis
    Disel, Umut
    Sivakumar, Smruthy
    Pham, Tim
    Fleischmann, Zoe
    Anu, R., I
    Sokol, Ethan S.
    Kurzrock, Razelle
    ONCOLOGIST, 2024, 29 (02): : e213 - e223
12345